慢性胰腺炎患者消化不良的诊治进展

胡良皞; 金震东

doi:10.3969/j.issn.1001-5256.2023.12.002

慢性胰腺炎患者消化不良的诊治进展

DOI: 10.3969/j.issn.1001-5256.2023.12.002

胡良皞,
金震东^, ,

海军军医大学第一附属医院消化内科，上海 200433

利益冲突声明：本文不存在任何利益冲突。

作者贡献声明：胡良皞负责资料分析和文章撰写；金震东负责研究指导和论文修改。

详细信息

通信作者:
金震东， zhendjin@126.com （ORCID： 0000-0003-1196-9047）

计量
- 文章访问数: 499
- HTML全文浏览量: 140
- PDF下载量: 112
- 被引次数: 0
出版历程
- 收稿日期: 2023-09-03
- 录用日期: 2023-10-08
- 出版日期: 2023-12-12

Advances in the diagnosis and treatment of dyspepsia in chronic pancreatitis patients

Lianghao HU,
Zhendong JIN^{,
,}

Department of Gastroenterology，The First Affiliated Hospital of Navy Medical University，Shanghai 200433，China

More Information

Corresponding author: JIN Zhendong， zhendjin@126.com （ORCID： 0000-0003-1196-9047）

摘要

摘要: 消化不良是临床常见的一组症状，可以分为器质性和功能性两类。慢性胰腺炎（CP）时常出现脂肪泻、腹胀、腹痛等消化不良症状，其中大部分患者伴有胰腺外分泌功能不全（PEI），属于器质性消化不良。临床上，PEI和消化不良的诊断需综合评估患者的临床表现、营养状况和胰腺外分泌功能，并以此制订个性化的治疗方案。但部分患者外分泌功能良好却有消化不良的症状，其诊断和治疗仍为临床难点。本文针对CP患者消化不良的诊治研究进展进行综述。
- 胰腺炎，慢性 /
- 胰腺外分泌功能不全 /
- 消化不良 /
- 诊断 /
- 治疗学
Abstract: Dyspepsia is a common group of clinical symptoms and can be classified into organic and functional dyspepsia. Patients with chronic pancreatitis （CP） often have the symptoms of dyspepsia such as fatty diarrhea， abdominal distention， and abdominal pain， and most patients have pancreatic exocrine insufficiency （PEI）， which belongs to organic dyspepsia. In clinical practice， the diagnosis of PEI and dyspepsia requires a comprehensive assessment of clinical manifestations， nutritional status， and pancreatic exocrine function， and an individualized treatment regimen should be developed based on such factors. However， some patients with normal exocrine function may have the symptoms of dyspepsia， and the diagnosis and treatment of such patients are still difficulties in clinical practice. This article reviews the advances in the diagnosis and treatment of dyspepsia in CP patients.
- Pancreatitis， Chronic /
- Exocrine Pancreatic Insufficiency /
- Dyspepsia /
- Diagnosis /
- Therapeutics

HTML全文

参考文献(40)

[1]	FORD AC, MAHADEVA S, CARBONE MF, et al. Functional dyspepsia[J]. Lancet, 2020, 396( 10263): 1689- 1702. DOI: 10.1016/S0140-6736(20)30469-4.
[2]	VEGE SS, CHARI ST. Chronic pancreatitis[J]. N Engl J Med, 2022, 386( 9): 869- 878. DOI: 10.1056/nejmcp1809396.
[3]	LIU Y, YIN XY, WANG D, et al. Risk factor analysis and nomogram development for steatorrhea in idiopathic chronic pancreatitis[J]. J Dig Dis, 2022, 23( 5-6): 331- 340. DOI: 10.1111/1751-2980.13102.
[4]	HAO L, WANG LS, LIU Y, et al. The different course of alcoholic and idiopathic chronic pancreatitis: A long-term study of 2, 037 patients[J]. PLoS One, 2018, 13( 6): e0198365. DOI: 10.1371/journal.pone.0198365.
[5]	CAMPAGNOLA P, de PRETIS N, ZORZI A, et al. Chronic pancreatitis and nutritional support[J]. Best Pract Res Clin Gastroenterol, 2023, 62-63: 101823. DOI: 10.1016/j.bpg.2023.101823.
[6]	QU AIN, BASHIR Y, KELLEHER L, et al. Dietary intake in patients with chronic pancreatitis: A systematic review and meta-analysis[J]. World J Gastroenterol, 2021, 27( 34): 5775- 5792. DOI: 10.3748/wjg.v27.i34.5775.
[7]	ERCHINGER F, ENGJOM T, DIMCEVSKI G, et al. Exocrine pancreas insufficiency in chronic pancreatitis-Risk factors and associations with complications. A multicentre study of 1869 patients[J]. Pancreatology, 2022, 22( 3): 374- 380. DOI: 10.1016/j.pan.2022.02.003.
[8]	CAÑAMARES-ORBÍS P, GARCÍA-RAYADO G, ALFARO-ALMAJANO E. Nutritional support in pancreatic diseases[J]. Nutrients, 2022, 14( 21): 4570. DOI: 10.3390/nu14214570.
[9]	MARTÍNEZ-MONEO E, STIGLIANO S, HEDSTRÖM A, et al. Deficiency of fat-soluble vitamins in chronic pancreatitis: A systematic review and meta-analysis[J]. Pancreatology, 2016, 16( 6): 988- 994. DOI: 10.1016/j.pan.2016.09.008.
[10]	HOOGENBOOM SA, LEKKERKERKER SJ, FOCKENS P, et al. Systematic review and meta-analysis on the prevalence of vitamin D deficiency in patients with chronic pancreatitis[J]. Pancreatology, 2016, 16( 5): 800- 806. DOI: 10.1016/j.pan.2016.07.010.
[11]	LINDKVIST B, DOMÍNGUEZ-MUÑOZ JE, LUACES-REGUEIRA M, et al. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis[J]. Pancreatology, 2012, 12( 4): 305- 310. DOI: 10.1016/j.pan.2012.04.006.
[12]	VUJASINOVIC M, HEDSTRÖM A, MAISONNEUVE P, et al. Zinc deficiency in patients with chronic pancreatitis[J]. World J Gastroenterol, 2019, 25( 5): 600- 607. DOI: 10.3748/wjg.v25.i5.600.
[13]	HART PA, YADAV D, LI L, et al. High prevalence of osteopathy in chronic pancreatitis: A cross-sectional analysis from the PROCEED study[J]. Clin Gastroenterol Hepatol, 2022, 20( 9): 2005- 2013. DOI: 10.1016/j.cgh.2021.09.026.
[14]	KUAN LL, DENNISON AR, GARCEA G. Prevalence and impact of sarcopenia in chronic pancreatitis: A review of the literature[J]. World J Surg, 2021, 45( 2): 590- 597. DOI: 10.1007/s00268-020-05828-0.
[15]	de la IGLESIA D, VALLEJO-SENRA N, LÓPEZ-LÓPEZ A, et al. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study[J]. J Gastroenterol Hepatol, 2019, 34( 1): 277- 283. DOI: 10.1111/jgh.14460.
[16]	CARNIE LE, LAMARCA A, MCNAMARA MG, et al. The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: In need of a new gold-standard[J]. Pancreatology, 2020, 20( 4): 668- 675. DOI: 10.1016/j.pan.2020.03.020.
[17]	SWENSSON J, ZAHEER A, CONWELL D, et al. Secretin-enhanced MRCP: How and why- AJR expert panel narrative review[J]. AJR Am J Roentgenol, 2021, 216( 5): 1139- 1149. DOI: 10.2214/AJR.20.24857.
[18]	MIYAKE H, SAKAGAMI J, YASUDA H, et al. Association of fatty pancreas with pancreatic endocrine and exocrine function[J]. PLoS One, 2018, 13( 12): e0209448. DOI: 10.1371/journal.pone.0209448.
[19]	DIÉGUEZ-CASTILLO C, JIMÉNEZ-LUNA C, PRADOS J, et al. State of the art in exocrine pancreatic insufficiency[J]. Medicina, 2020, 56( 10): 523. DOI: 10.3390/medicina56100523.
[20]	PHILLIPS ME, HOPPER AD, LEEDS JS, et al. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines[J]. BMJ Open Gastroenterol, 2021, 8( 1): e000643. DOI: 10.1136/bmjgast-2021-000643.
[21]	VANGA RR, TANSEL A, SIDIQ S, et al. Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: Systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2018, 16( 8): 1220- 1228. DOI: 10.1016/j.cgh.2018.01.027.
[22]	GONZÁLEZ-SÁNCHEZ V, AMRANI R, GONZÁLEZ V, et al. Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: ¹³C-Mixed Triglyceride Breath Test versus Fecal Elastase[J]. Pancreatology, 2017, 17( 4): 580- 585. DOI: 10.1016/j.pan.2017.03.002.
[23]	DOMÍNGUEZ-MUÑOZ JE, de la IGLESIA-GARCÍA D, NIETO-GARCÍA L, et al. Endoscopic pancreatic drainage improves exocrine pancreatic function in patients with unresectable pancreatic cancer: A double-blind, prospective, randomized, single-center, interventional study[J]. Pancreas, 2021, 50( 5): 679- 684. DOI: 10.1097/MPA.0000000000001817.
[24]	de la IGLESIA-GARCÍA D, HUANG W, SZATMARY P, et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: Systematic review and meta-analysis[J]. Gut, 2017, 66( 8): 1354- 1355. DOI: 10.1136/gutjnl-2016-312529.
[25]	DOMINGUEZ-MUNOZ JE, DREWES AM, LINDKVIST B, et al. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis[J]. Pancreatology, 2018, 18( 8): 847- 854. DOI: 10.1016/j.pan.2018.09.016.
[26]	GARDNER TB, ADLER DG, FORSMARK CE, et al. ACG clinical guideline: Chronic pancreatitis[J]. Am J Gastroenterol, 2020, 115( 3): 322- 339. DOI: 10.14309/ajg.0000000000000535.
[27]	Special Committee on Chronic Pancreatitis, Pancreatic Disease Specialized Committee, Chinese Medical Doctor Association. Standards for the diagnosis and treatment of pancreatic exocrine insufficiency(2018, Guangzhou)[J]. J Clin Hepatol, 2019, 35( 2): 294- 298. DOI: 10.3969/j.issn.1001-5256.2019.02.010. 中国医师协会胰腺病专业委员会慢性胰腺炎专委会. 胰腺外分泌功能不全诊治规范(2018,广州)[J]. 临床肝胆病杂志, 2019, 35( 2): 294- 298. DOI: 10.3969/j.issn.1001-5256.2019.02.010.
[28]	Working Party of the Australasian Pancreatic Club, SMITH RC, SMITH SF, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency[J]. Pancreatology, 2016, 16( 2): 164- 180. DOI: 10.1016/j.pan.2015.12.006.
[29]	DOMÍNGUEZ-MUÑOZ JE, IGLESIAS-GARCÍA J, IGLESIAS-REY M, et al. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: A randomized, three-way crossover study[J]. Aliment Pharmacol Ther, 2005, 21( 8): 993- 1000. DOI: 10.1111/j.1365-2036.2005.02390.x.
[30]	ERCHINGER F, TJORA E, NORDAAS IK, et al. Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines-a cross-sectional observational study[J]. United European Gastroenterol J, 2022, 10( 8): 844- 853. DOI: 10.1002/ueg2.12276.
[31]	SERÓN-ARBELOA C, LABARTA-MONZÓN L, PUZO-FONCILLAS J, et al. Malnutrition screening and assessment[J]. Nutrients, 2022, 14( 12): 2392. DOI: 10.3390/nu14122392.
[32]	SANDER-STRUCKMEIER S, BECKMANN K, JANSSEN-VAN SOLINGEN G, et al. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin(CREON^®) in patients with pancreatic exocrine insufficiency[J]. Pancreas, 2013, 42( 6): 983- 989. DOI: 10.1097/MPA.0b013e31828784ef.
[33]	TALLEY NJ, HOLTMANN G, NGUYEN QN, et al. Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain[J]. J Gastroenterol Hepatol, 2017, 32( 11): 1813- 1817. DOI: 10.1111/jgh.13791.
[34]	FORD AC, MARWAHA A, SOOD R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: A meta-analysis[J]. Gut, 2015, 64( 7): 1049- 1057. DOI: 10.1136/gutjnl-2014-307843.
[35]	ARVANITAKIS M, OCKENGA J, BEZMAREVIC M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis[J]. Clin Nutr, 2020, 39( 3): 612- 631. DOI: 10.1016/j.clnu.2020.01.004.
[36]	MADRO A. Malnutrition in chronic pancreatitis: Causes, assessment methods, and therapeutic management[J]. Can J Gastroenterol Hepatol, 2020, 2020: 8875487. DOI: 10.1155/2020/8875487.
[37]	FORD AC, MOAYYEDI P, BLACK CJ, et al. Systematic review and network meta-analysis: Efficacy of drugs for functional dyspepsia[J]. Aliment Pharmacol Ther, 2021, 53( 1): 8- 21. DOI: 10.1111/apt.16072.
[38]	BLACK CJ, PAINE PA, AGRAWAL A, et al. British Society of Gastroenterology guidelines on the management of functional dyspepsia[J]. Gut, 2022, 71( 9): 1697- 1723. DOI: 10.1136/gutjnl-2022-327737.
[39]	FORD AC, TSIPOTIS E, YUAN YH, et al. Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: Updated systematic review and meta-analysis[J]. Gut, 2022. DOI: 10.1136/gutjnl-2021-326583.[ Online ahead of print]
[40]	SAYUK GS, GYAWALI CP. Functional dyspepsia: Diagnostic and therapeutic approaches[J]. Drugs, 2020, 80( 13): 1319- 1336. DOI: 10.1007/s40265-020-01362-4.